Gary Cupit

Gary Cupit currently serves as Chairman of the Board at KeViRx, Inc. and as a Member of the Board at Liquet Medical Inc., where the focus is on reimagining vascular drug delivery. Cupit holds advisory roles at KeVIRx and acts as a Senior Advisor for Frontcourt Group LLC. Previous leadership positions include CEO and Director at Microvation Therapeutics, where a treatment for Clostridium difficile infections was developed, and CEO and Director at Somnus Therapeutics. Cupit's extensive experience in the pharmaceutical industry includes significant roles at Novartis, where responsibilities involved global business development and search and evaluation. Gary Cupit earned a BSc in Pharmacy from the Medical College of Virginia and a PharmD from the University of the Sciences in Philadelphia, with additional education from Old Dominion University.